Document is current
Any future updates will be listed below
-
Authors
Watson, C. James
Simpson, Michael D.
Saraiya, Nishita
Wilkosz, Christopher A.
Yu, Michael B.
Burns, Michele M.
Neavyn, Mark J.
Simone, Karen E.
Strout, Tania D.
-
Funding
Funding for this research was provided by:
NIH (K12TR004384)
NIH (T32HL155020)
NIH (U54GM115516)
- License Information
-
More Information
Article History
Received: 26 November 2025
Revised: 28 January 2026
Accepted: 12 February 2026
First Online: 19 March 2026
Declarations
:
: Author CJW discloses that he received additional subaward fundingover the past three years, unrelated to this project: the National Institutes of Health / NationalInstitute on Drug Abuse, Grant Number R25DA58490 (American College of Medical ToxicologyANTIDOTE Institute). He has additional subaward funding pending, unrelated to this project: TheNational Institutes of Health / National Institute of General Medical Sciences, Grant NumberP20GM139745 (COBRE in Acute Care Research & Rural Health). Author MDS discloses that hereceived additional subaward funding over the past three years, unrelated to this project: theNational Institutes of Health / National Institute on Drug Abuse, Grant Number R25DA58490(American College of Medical Toxicology ANTIDOTE Institute). Author MMB discloses that shereceives payment as Pediatric Toxicology Section Editor from UpToDate. Authors NS, CAW, MBY,MJN, KES, and TDS declare that they have no conflicts of interest.
